In Vitro Models Mimicking Immune Response in the Skin

키워드

참고문헌 (119)

1. Nestle FO, "Skin immune sentinels in health and disease", Nat Rev Immunol, 9, pp.679~691 (2009)
2. De Vuyst E, "Atopic dermatitis studies through in vitro models", Front Med (Lausanne), 4, pp.119~ (2017)
3. Kapałczyn´ ska M, "2D and 3D cell cultures-a comparison of different types of cancer cell cultures", Arch Med Sci, 14, pp.910~919 (2018)
4. Reus AA, "The use of ex vivo human skin tissue for genotoxicity testing", Toxicol Appl Pharmacol, 261, pp.154~163 (2012)
5. Ackermann K, "The Phenion Full-Thickness Skin model for percutaneous absorption testing", Skin Pharmacol Physiol, 23, pp.105~112 (2010)
6. Frankart A, "Epidermal morphogenesis during progressive in vitro 3D reconstruction at the air-liquid interface", Exp Dermatol, 21, pp.871~875 (2012)
7. Murphy KM, "Janeway’s immunobiology" (2016), Garland Science, Taylor & Francis Group
8. Barker JN, "Keratinocytes as initiators of inflammation", Lancet, 337, pp.211~214 (1991)
9. Black AP, "Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells", Eur J Immunol, 37, pp.1485~1493 (2007)
10. Kabashima K, "The immunological anatomy of the skin", Nat Rev Immunol, 19, pp.19~30 (2019)
11. Bennett CL, "Editorial : langerhans cells and how skin pathology reshapes the local immune environment", Front Immunol, 10, pp.139~ (2019)
12. Clark RA, "The vast majority of CLA+ T cells are resident in normal skin", J Immunol, 176, pp.4431~4439 (2006)
13. Jiang X, "Skin infection generates non-migratory memory CD8+ T(RM)cells providing global skin immunity", Nature, 483, pp.227~231 (2012)
14. )cells in the absence of persisting local antigen presentation, "Proc Natl Acad Sci U S A", 2012, 7037~7042
15. Smith RS, "Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation", Am J Pathol, 151, pp.317~322 (1997)
16. Stingl G, "Dendritic cells : a major story unfolds", Immunol Today, 16, pp.330~333 (1995)
17. Skapenko A, "The role of the T cell in autoimmune inflammation", Arthritis Res Ther, 7(Suppl 2), pp.S4~S14 (2005)
18. Coias J, "T-cell polarization differs in various stages of discoid lupus erythematosus skin", Br J Dermatol, 182, pp.1291~1293 (2020)
19. Jäger A, "Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes", J Immunol, 183, pp.7169~7177 (2009)
20. Langan SM, "Atopic dermatitis", Lancet, 396, pp.345~360 (2020)
21. Saravia J, "Helper T cell differentiation", Cell Mol Immunol, 16, pp.634~643 (2019)
22. Patel DD, "Th17 cell pathway in human immunity : lessons from genetics and therapeutic interventions", Immunity, 43, pp.1040~1051 (2015)
23. Park CO, "Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection", J Allergy Clin Immunol, 142, pp.647~662 (2018)
24. Cesare AD, "A role for Th17 cells in the immunopathogenesis of atopic dermatitis?", J Invest Dermatol, 128, pp.2569~2571 (2008)
25. Ali N, "Regulatory T cells in skin", Immunology, 152, pp.372~381 (2017)
26. Vignali DA, "How regulatory T cells work", Nat Rev Immunol, 8, pp.523~532 (2008)
27. Sonnenberg GF, "Functional interactions between innate lymphoid cells and adaptive immunity", Nat Rev Immunol, 19, pp.599~613 (2019)
28. Vivier E, "Innate lymphoid cells : 10 years on", Cell, 174, pp.1054~1066 (2018)
29. Aderem A, "Mechanisms of phagocytosis in macrophages", Annu Rev Immunol, 17, pp.593~623 (1999)
30. van Furth R, "The characterization, origin, and kinetics of skin macrophages during inflammation", J Invest Dermatol, 85, pp.398~402 (1985)
31. Amin K, "The role of mast cells in allergic inflammation", Respir Med, 106, pp.9~14 (2012)
32. Pasparakis M, "Mechanisms regulating skin immunity and inflammation", Nat Rev Immunol, 14, pp.289~301 (2014)
33. Peters JH, "Co-culture of healthy human keratinocytes and T-cells promotes keratinocyte chemokine production and RORγt-positive IL-17 producing T-cell populations", J Dermatol Sci, 69, pp.44~53 (2013)
34. Akeda T, "CD8+ T cell granzyme B activates keratinocyte endogenous IL-18", Arch Dermatol Res, 306, pp.125~130 (2014)
35. Galbiati V, "Human keratinocytes and monocytes co-culture cell system : an important contribution for the study of moderate and weak sensitizers", Toxicol In Vitro, 68, pp.104929~ (2020)
36. Asselineau D, "Human epidermis reconstructed by culture: is it “normal”?", J Invest Dermatol, 86, pp.181~186 (1986)
37. Schäfer-Korting M, "Reconstructed epidermis and full-thickness skin for absorption testing : influence of the vehicles used on steroid permeation", Altern Lab Anim, 36, pp.441~452 (2008)
38. Auger FA, "Tissue-engineered skin substitutes : from in vitro constructs to in vivo applications", Biotechnol Appl Biochem, 39, pp.263~275 (2004)
39. Pennacchi PC, "Glycated reconstructed human skin as a platform to study the pathogenesis of skin aging", Tissue Eng Part A, 21, pp.2417~2425 (2015)
40. Poumay Y, "A simple reconstructed human epidermis : preparation of the culture model and utilization in in vitro studies", Arch Dermatol Res, 296, pp.203~211 (2004)
41. Régnier M, "Integration of Langerhans cells into a pigmented reconstructed human epidermis", J Invest Dermatol, 109, pp.510~512 (1997)
42. Bechetoille N, "Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells", Tissue Eng, 13, pp.2667~2679 (2007)
43. Ouwehand K, "Technical advance : Langerhans cells derived from a human cell line in a full-thickness skin equivalent undergo allergen-induced maturation and migration", J Leukoc Biol, 90, pp.1027~1033 (2011)
44. van den Bogaard EH, "Crosstalk between keratinocytes and T cells in a 3D microenvironment : a model to study inflammatory skin diseases", J Invest Dermatol, 134, pp.719~727 (2014)
45. Bechetoille N, "A new organotypic model containing dermal-type macrophages", Exp Dermatol, 20, pp.1035~1037 (2011)
46. Shin JU, "Recapitulating T cell infiltration in 3D psoriatic skin models for patient-specific drug testing", Sci Rep, 10, pp.4123~ (2020)
47. Parenteau NL, "Epidermis generated in vitro : practical considerations and applications", J Cell Biochem, 45, pp.245~251 (1991)
48. Stark HJ, "Epidermal homeostasis in long-term scaffold-enforced skin equivalents", J Investig Dermatol Symp Proc, 11, pp.93~105 (2006)
49. Li L, "The three-dimensional human skin reconstruct model : a tool to study normal skin and melanoma progression", J Vis Exp, (54), pp.2937~ (2011)
50. Parenteau-Bareil R, "Collagen-based biomaterials for tissue engineering applications", Materials (Basel), 3, pp.1863~1887 (2010)
51. Rehder J, "Model of human epidermis reconstructed in vitro with keratinocytes and melanocytes on dead de-epidermized human dermis", Sao Paulo Med J, 122, pp.22~25 (2004)
52. Tjabringa G, "Development and validation of human psoriatic skin equivalents", Am J Pathol, 173, pp.815~823 (2008)
53. Germain L, "Autologous bilayered self-assembled skin substitutes(SASSs)as permanent grafts : a case series of 14 severely burned patients indicating clinical effectiveness", Eur Cell Mater, 36, pp.128~141 (2018)
54. Climov M, "Bioengineered self-assembled skin as an alternative to skin grafts", Plast Reconstr Surg Glob Open, 4, pp.e731~ (2016)
55. Boguniewicz M, "Atopic dermatitis : a disease of altered skin barrier and immune dysregulation", Immunol Rev, 242, pp.233~246 (2011)
56. Gittler JK, "Progressive activation of T(H)2", T(H)22cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis, 2012, pp.130, 1344~1354
57. Cho SH, "Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model", J Invest Dermatol, 116, pp.658~663 (2001)
58. Nomura I, "Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis : a gene microarray analysis", J Allergy Clin Immunol, 112, pp.1195~1202 (2003)
59. Mihm MC Jr, "The structure of normal skin and the morphology of atopic eczema", J Invest Dermatol, 67, pp.305~312 (1976)
60. Pellerin L, "Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin", J Allergy Clin Immunol, 131, pp.1094~1102 (2013)
61. Jakasa I, "Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations", J Invest Dermatol, 131, pp.540~542 (2011)
62. Yosipovitch G, "What causes itch in atopic dermatitis?", Curr Allergy Asthma Rep, 8, pp.306~311 (2008)
63. Yosipovitch G, "Neuroimmune interactions in chronic itch of atopic dermatitis", J Eur Acad Dermatol Venereol, 34, pp.239~250 (2020)
64. Tamari M, "Immunosensation : neuroimmune cross talk in the skin", Annu Rev Immunol, 39, pp.369~393 (2021)
65. Jiao D, "NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation", Cell Mol Immunol, 13, pp.535~550 (2016)
66. Cheung PF, "Activation of human eosinophils and epidermal keratinocytes by Th2cytokine IL-31 : implication for the immunopathogenesis of atopic dermatitis", Int Immunol, 22, pp.453~467 (2010)
67. Renne J, "Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation", Br J Dermatol, 162, pp.1198~1205 (2010)
68. Danso MO, "TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents", J Invest Dermatol, 134, pp.1941~1950 (2014)
69. Bernard FX, "Keratinocytes under fire of proinflammatory cytokines : bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis", J Allergy (Cairo), 2012, pp.718725~ (2012)
70. De Vuyst É, "Methyl-β-cyclodextrin concurs with interleukin(IL)-4, IL-13 and IL-25 to induce alterations reminiscent of atopic dermatitis in reconstructed human epidermis", Exp Dermatol, 27, pp.435~437 (2018)
71. Gruber R, "Diverse regulation of claudin-1 and claudin-4in atopic dermatitis", Am J Pathol, 185, pp.2777~2789 (2015)
72. Yuki T, "Impaired tight junctions in atopic dermatitis skin and in a skinequivalent model treated with interleukin-17", PLoS One, 11, pp.e0161759~ (2016)
73. Pendaries V, "Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation", J Invest Dermatol, 134, pp.2938~2946 (2014)
74. Pendaries V, ";" (2015), e1656
75. Niehues H, "Epidermal equivalents of filaggrin null keratinocytes do not show impaired skin barrier function", J Allergy Clin Immunol, 139, pp.1979~1981 (2017)
76. Berroth A, "Role of fibroblasts in the pathogenesis of atopic dermatitis", J Allergy Clin Immunol, 131, pp.1547~1554 (2013)
77. Sriram G, "Full-thickness human skin equivalent models of atopic dermatitis", Methods Mol Biol, 1879, pp.367~383 (2019)
78. Kamsteeg M, "Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent", Am J Pathol, 178, pp.2091~2099 (2011)
79. Lee SH, "Ameliorating effect of dipotassium glycyrrhizinate on an IL-4-and IL-13-induced atopic dermatitis-like skin-equivalent model", Arch Dermatol Res, 311, pp.131~140 (2019)
80. Hönzke S, "Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and β-defensins in filaggrin-deficient skin equivalents", J Invest Dermatol, 136, pp.631~639 (2016)
81. Engelhart K, "In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models", Arch Dermatol Res, 297, pp.1~9 (2005)
82. Wallmeyer L, "TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents", Sci Rep, 7, pp.774~ (2017)
83. Lebonvallet N, "Effects of the re-innervation of organotypic skin explants on the epidermis", Exp Dermatol, 21, pp.156~158 (2012)
84. Roggenkamp D, "Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model", J Invest Dermatol, 133, pp.1620~1628 (2013)
85. Vidal SEL, "3D biomaterial matrix to support long term, full thickness, immuno-competent human skin equivalents with nervous system components", Biomaterials, 198, pp.194~203 (2019)
86. Abbott RD, "The use of silk as a scaffold for mature, sustainable unilocular adipose 3D tissue engineered systems", Adv Healthc Mater, 5, pp.1667~1677 (2016)
87. Vidal Yucha SE, "Human skin equivalents demonstrate need for neuro-immuno-cutaneous system", Adv Biosyst, 3, pp.e1800283~ (2019)
88. Chiricozzi A, "Scanning the immunopathogenesis of psoriasis", Int J Mol Sci, 19, pp.179~ (2018)
89. Deng Y, "The inflammatory response in psoriasis : a comprehensive review", Clin Rev Allergy Immunol, 50, pp.377~389 (2016)
90. Kim J, "The immunopathogenesis of psoriasis", Dermatol Clin, 33, pp.13~23 (2015)
91. Albanesi C, "Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment", J Exp Med, 206, pp.249~258 (2009)
92. Albanesi C, "Resident skin cells in psoriasis : a special look at the pathogenetic functions of keratinocytes", Clin Dermatol, 25, pp.581~588 (2007)
93. Bellinato F, "Latest advances for the treatment of chronic plaque psoriasis with biologics and oral small molecules", Biologics, 15, pp.247~253 (2021)
94. Martin G, "Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis : necessity of direct cell-tocell contact", Lab Invest, 92, pp.1058~1070 (2012)
95. Muhr P, "Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells", Exp Dermatol, 19, pp.1105~1107 (2010)
96. Sa SM, "The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis", J Immunol, 178, pp.2229~2240 (2007)
97. Krueger GG, "Experimental models for psoriasis", J Invest Dermatol, 95(5 Suppl), pp.56S~58S (1990)
98. Konstantinova NV, "Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts", J Invest Dermatol, 107, pp.615~621 (1996)
99. Barker CL, "The development and characterization of an in vitro model of psoriasis", J Invest Dermatol, 123, pp.892~901 (2004)
100. Jean J, "Development of an in vitro psoriatic skin model by tissue engineering", J Dermatol Sci, 53, pp.19~25 (2009)
101. Harvey A, "MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model", Proteomics, 16, pp.1718~1725 (2016)
102. Rüffer C, "Psoriatic in vitro epidermis-a human tissue culture model for testing cosmetical and medical skin care products", H&PC Today, 2, pp.30~32 (2011)
103. Clarysse K, "JAK1", 3 inhibition preserves epidermal morphology in full-thickness 3D skin models of atopic dermatitis and psoriasis, 2019, pp.33, 367~375
104. Jansen PA, "Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin", PLoS One, 4, pp.e4725~ (2009)
105. Pouliot-Bérubé C, "Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis", Regen Med, 11, pp.545~557 (2016)
106. Nograles KE, "Th17 cytokines interleukin(IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways", Br J Dermatol, 159, pp.1092~1102 (2008)
107. Chiricozzi A, "IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model", PLoS One, 9, pp.e90284~ (2014)
108. Bhatia SN, "Microfluidic organs-on-chips", Nat Biotechnol, 32, pp.760~772 (2014)
109. Wufuer M, "Skin-ona-chip model simulating inflammation, edema and drug-based treatment", Sci Rep, 6, pp.37471~ (2016)
110. Ramadan Q, "In vitro micro-physiological immunecompetent model of the human skin", Lab Chip, 16, pp.1899~1908 (2016)
111. Ren X, "Investigations on T cell transmigration in a human skinon-chip(SoC)model", Lab Chip, 21, pp.1527~1539 (2021)
112. Kwak BS, "Microfluidic skin chip with vasculature for recapitulating the immune response of the skin tissue", Biotechnol Bioeng, 117, pp.1853~1863 (2020)
113. Abaci HE, "Tissue engineering of human hair follicles using a biomimetic developmental approach", Nat Commun, 9, pp.5301~ (2018)
114. Zoio P, "Pigmented full-thickness human skin model based on a fibroblast-derived matrix for longterm studies", Tissue Eng Part C Methods, 27, pp.433~443 (2021)
115. Ponec M, "Endothelial network formed with human dermal microvascular endothelial cells in autologous multicellular skin substitutes", Angiogenesis, 7, pp.295~305 (2004)
116. Bellas E, "In vitro 3D full-thickness skin-equivalent tissue model using silk and collagen biomaterials", Macromol Biosci, 12, pp.1627~1636 (2012)
117. Gledhill K, "Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells", PLoS One, 10, pp.e0136713~ (2015)
118. Itoh M, "Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells(iPSCs)", PLoS One, 8, pp.e77673~ (2013)
119. Abaci HE, "Human skin constructs with spatially controlled vasculature using primary and iPSC-derived endothelial cells", Adv Healthc Mater, 5, pp.1800~1807 (2016)

관련 논문AI추천